Sitemap

November 30, 2022 Articles

Filter by Available Specialty
  1. ‘No one should be dying’ of HCV with currently available diagnostics, treatment
  2. ACP advocates for better correctional health care in US
  3. ACP releases living practice points on COVID-19 treatment in outpatient settings
  4. ASCO survey: Prior authorization leads to ‘indefensible delays’ in cancer care
  5. Bariatric surgery lowers risk for any CV outcome among adults with severe obesity, NAFLD
  6. Cajal launches with $96M to advance therapeutics for neurodegenerative disease
  7. CATCR-T cell therapy may aid in antiphospholipid syndrome through selective B-cell depletion
  8. CDC to expand wastewater testing for poliovirus
  9. Clinicians ‘never too old or too young’ to use social media
  10. Concurrent ADT, radiation therapy improves outcomes in localized prostate cancer
  11. Consider other triggers beyond food in treating atopic dermatitis
  12. Developing Plans for Patient and Trainee Education with Daniel Golden, MD
  13. Experts, patients propose recommendations to improve clinical care of pediatric CKD
  14. FDA grants priority review to evinacumab-dgnb for pediatric HoFH indication
  15. Gastrointestinal symptoms may indicate eosinophilic esophagitis among adults with atopy
  16. Guideline addresses use of integrative therapies for cancer-related pain management
  17. Healio Minute Podcast, Hematology Oncology Edition: Top Headlines - Week of November 28, 2022
  18. Healio’s Disruptive Innovators celebrate at ACG 2022
  19. Institutions with more racially diverse, uninsured patients linked with surgical delays
  20. Intimate partner violence screening needed in pregnant patients with certain injuries
  21. Lecanemab reduces amyloid, slows cognitive decline in early Alzheimer’s disease
  22. Medicaid in ‘most states’ provides HPV vaccination coverage through age 45 years
  23. Multidisciplinary WCIRDC meeting honors cardiometabolic research pioneer
  24. National HCV elimination program a ‘golden opportunity’ to improve lives
  25. National Kidney Registry expands living donor protection, paid leave policy to employees
  26. Pancreatic cancer screening yields moderate benefit, ‘no harms’ for high-risk patients
  27. Phase 2 trial initiated for depression treatment targeting specific biomarker
  28. Phenotype-tailored diets ‘set patients up for success’ in weight loss, health outcomes
  29. Premium IOLs still an option in post-refractive eyes
  30. Prenatal cannabis exposure may increase pregnancy risks
  31. Prenatal cannabis use more common in areas with greater retail availability
  32. Proposed revisions to Diabetes Distress Scale to benefit Spanish speakers
  33. Q&A: Investigational therapy shows potential for treating patients with IPF
  34. Recent developments driving the 'evolution' of lung cancer treatments
  35. Safety data supports ruxolitinib for long-term treatment of atopic dermatitis
  36. Short-term adverse events low with novel TAVR system
  37. Source of fungal lung infections has spread outside historical borders
  38. Study participants ‘extremely happy’ with Biotrue, habitual contact lenses
  39. Survey finds most PCPs believe melatonin is a recommended insomnia treatment
  40. Switching from adalimumab to upadacitinib demonstrates clinical improvement for patients with RA
  41. Top in endocrinology: Plant-based Portfolio diet; osteoporosis remains undiagnosed
  42. Top-line results: Vibration belt slows bone strength decline among adults with osteopenia
  43. Undernutrition before TB, after treatment initiation associated with adverse outcomes
  44. Underweight, obesity predict worse outcomes during invasive coronary procedures
  45. Use of contraception decreases after breast cancer diagnosis
  46. VIDEO: Autologous retinal transplant shows efficacy for myopic macular holes
  47. VIDEO: Joint aspiration may not predict residual infection prior to reimplantation
  48. VIDEO: Larotrectinib shows efficacy, deep learning AI promise for finding NTRK fusions
  49. VIDEO: New data on medullary thyroid cancer at American Thyroid Association Annual Meeting
  50. VIDEO: Pegcetacoplan shows positive 2-year results in geographic atrophy reduction